Related references
Note: Only part of the references are listed.Immucillins in Infectious Diseases
Gary B. Evans et al.
ACS INFECTIOUS DISEASES (2018)
Crystallographic snapshots of ligand binding to hexameric purine nucleoside phosphorylase and kinetic studies give insight into the mechanism of catalysis
Zoran Stefanic et al.
SCIENTIFIC REPORTS (2018)
Structural characterization of purine nucleoside phosphorylase from human pathogen Helicobacter pylori
Zoran Stefanic et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
Functional and Structural Characterization of Purine Nucleoside Phosphorylase from Kluyveromyces lactis and Its Potential Applications in Reducing Purine Content in Food
Durga Mahor et al.
PLOS ONE (2016)
Isotope-specific and amino acid-specific heavy atom substitutions alter barrier crossing in human purine nucleoside phosphorylase
Javier Suarez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Inhibition and Structure of Toxoplasma gondii Purine Nucleoside Phosphorylase
Teraya M. Donaldson et al.
EUKARYOTIC CELL (2014)
Catalytic Site Conformations in Human PNP by 19F-NMR and Crystallography
Javier Suarez et al.
CHEMISTRY & BIOLOGY (2013)
Plasmodium falciparum Parasites Are Killed by a Transition State Analogue of Purine Nucleoside Phosphorylase in a Primate Animal Model
Maria B. Cassera et al.
PLOS ONE (2011)
Conformational States of Human Purine Nucleoside Phosphorylase at Rest, at Work, and with Transition State Analogues
Achelle A. Edwards et al.
BIOCHEMISTRY (2010)
9-Deazaguanine derivatives connected by a linker to difluoromethylene phosphonic acid are slow-binding picomolar inhibitors of trimeric purine nucleoside phosphorylase
Katarzyna Breer et al.
FEBS JOURNAL (2010)
Altered Enthalpy-Entropy Compensation in Picomolar Transition State Analogues of Human Purine Nucleoside Phosphorylase
Achelle A. Edwards et al.
BIOCHEMISTRY (2009)
Plasmodium falciparum Purine Nucleoside Phosphorylase Is Critical for Viability of Malaria Parasites
Dennis C. Madrid et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Inference of macromolecular assemblies from crystalline state
Evgeny Krissinel et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Novel multisubstrate inhibitors of mammalian purine nucleoside phosphorylase
AV Toms et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2005)
Assignment of downfield proton resonances in purine nucleoside phosphorylase•immucillin-H complex by saturation-transferred NOEs
H Deng et al.
BIOCHEMISTRY (2004)
Transition state analysis for human and Plasmodium falciparum purine nucleoside phosphorylases
A Lewandowicz et al.
BIOCHEMISTRY (2004)
Activating the phosphate nucleophile at the catalytic site of purine nucleoside phosphorylase: A vibrational spectroscopic study
H Deng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Achieving the ultimate physiological goal in transition state analogue inhibitors for purine nucleoside phosphorylase
A Lewandowicz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Interactions of potent multisubstrate analogue inhibitors with purine nucleoside phosphorylase from calf spleen - Kinetic and spectrofluorimetric studies
M Iwanow et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2003)
Transition state analogue inhibitors of purine nucleoside phosphorylase from Plasmodium falciparum
GA Kicska et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Open and closed conformation of the E-coli purine nucleoside phosphorylase active center and implications for the catalytic mechanism
G Koellner et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes
GA Kicska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Purine nucleoside phosphorylases: properties, functions, and clinical aspects
A Bzowska et al.
PHARMACOLOGY & THERAPEUTICS (2000)
Synthesis and evaluation of multisubstrate analogue inhibitors of purine nucleoside phosphorylases
T Yokomatsu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2000)
Share Paper
